SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-003736
Filing Date
2023-11-20
Accepted
2023-11-20 07:03:18
Documents
6
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 6-K zk2330575.htm 6-K 10604
2 PRESS RELEASE exhibit_1.htm EX-99 360237
3 INTERIM FINANCIAL STATEMENTS exhibit_2.htm EX-99 389567
4 OPERATING AND FINANCIAL REVIEW exhibit_3.htm EX-99 204889
5 image0.jpg GRAPHIC 111725
6 image2.jpg GRAPHIC 64227
  Complete submission text file 0001178913-23-003736.txt   1208618
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 231420695
SIC: 2834 Pharmaceutical Preparations